• Notice
  • Society for the Study of Super-Different Fields

Osaka Forum] Mr. Masayo Takahashi of RIKEN will deliver the keynote speech at the Japan Society for Hyperdifferential Research, Osaka Forum 2019 on Saturday, May 18, 2019!

2019.03.12
【大阪フォーラム】5/18(土)超異分野学会 大阪フォーラム2019 基調講演に理化学研究所の高橋政代氏が登壇します!

Liverness, Inc. will be hosting the Super Interdisciplinary Society Osaka Forum 2019 on Saturday, May 18, 2019. We are pleased to announce that the keynote speaker will be Dr. Masayo Takahashi of the RIKEN Center for Frontier Biosciences, who will discuss the current status and future of regenerative medicine, including the treatment of eye diseases based on regenerative medicine using iPS cells.
Other sessions are being planned under the theme of "Creating a new axis of medicine, food, and housing - Omoroi future blueprint from Kansai. We will inform you as soon as they are decided. We look forward to seeing you there.

For more information and registration, please contactthis way (direction close to the speaker or towards the speaker)from (e.g. time, place, numerical quantity)

The Society of Hyperdifferential Studies Osaka Forum 2019 Overview

Date : Saturday, May 18, 2019, 9:00 a.m. - 6:00 p.m. (eve of the festival: Friday, May 17, 7:00 p.m. @ Bentencho is scheduled)
Venue : ATC Hall O's South 6F Conference Room (2-1-10 Nanko-Kita, Suminoe-ku, Osaka City)
Participants: Academia, venture companies, large companies, small and medium-sized companies, leading regional companies, local factories, local governments, junior high and high school students
Keywords: Health, Drug Discovery/Medicine, Food, Life, Education, Well-Being, 100-year Life Era, Blueprint for the Future, etc.

 

keynote speech

Masayo Takahashi, M.D., Ph.
RIKEN Center for Frontier Biosciences

Project Leader, Retinal Regenerative Medicine R&D Project

"Future Medicine with iPS Cells (tentative)

iPS cells" became widely known after winning the Nobel Prize in Physiology or Medicine in 2012. Currently, its research has developed to the point where clinical trials are being conducted around the world with a view to human application. In this forum, Dr. Masayo Takahashi, who aims to establish treatments for retinal diseases such as age-related macular degeneration and retinitis pigmentosa from the viewpoint of regenerative medicine using iPS cells, will talk about the current status and future of regenerative medicine, including treatments for eye diseases based on regenerative medicine using iPS cells.

<Brief Biography

D. from Kyoto University Graduate School of Medicine in 1992. After working as an assistant at Kyoto University School of Medicine, he became a researcher at the Salk Institute in 1995, where he discovered the possibility of using stem cells for retinal therapy. He started clinical research on autologous iPS cell-derived retinal pigment epithelial sheet transplantation for exudative age-related macular degeneration and transplanted the first case in September 2014. In March 2017, he performed a transplantation using a suspension of retinal pigment epithelial cells derived from other iPS cells.

 

Conference Theme:
Creating a new axis of medicine, food, and housing - Omoroi Future Blueprint from Kansai

Osaka, known as "the kitchen of the nation," has been attracting "people, goods, and money" since the Edo period (1603-1868), and has developed through the mixing of diverse things. Even today, this culture is deeply rooted in the city. Research findings at world-class research institutes and universities and technological developments at leading Japanese companies are fusing together to create world-first discoveries. In the near future, will we be able to know our own health, prevent illness, freely obtain foodstuffs when we want to eat them, and live a comfortable, stress-free life? This forum will focus on "medicine," a field in which Kansai has an advantage, and "food and housing," a field with a unique culture, bringing together junior high and high school students, university students, researchers, and companies to discuss and create a blueprint for the future that can be called "omoroi" (omoroi).

For more information and registration, please contactthis way (direction close to the speaker or towards the speaker)from (e.g. time, place, numerical quantity)

 

For inquiries regarding this matter, please contact
Osaka Head Office, LIVERNESS Co.
Attn: FUKUDA, ISOGAI
Osaka Bay Tower Office 6F, 1-2-1 Benten, Minato-ku, Osaka, 552-0007, Japan
TEL:06-6125-5622 FAX:050-3737-5299
E-Mail: [email protected]

en_USEnglish